Cargando…

A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?

BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understandin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Dan, Zhai, Xiaoqian, Zhou, Yuwen, Xie, Yao, Tang, Liansha, Yin, Liyuan, Liu, Hangtian, Li, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469157/
https://www.ncbi.nlm.nih.gov/pubmed/36111011
http://dx.doi.org/10.21037/atm-22-3717
_version_ 1784788578445819904
author Pu, Dan
Zhai, Xiaoqian
Zhou, Yuwen
Xie, Yao
Tang, Liansha
Yin, Liyuan
Liu, Hangtian
Li, Lu
author_facet Pu, Dan
Zhai, Xiaoqian
Zhou, Yuwen
Xie, Yao
Tang, Liansha
Yin, Liyuan
Liu, Hangtian
Li, Lu
author_sort Pu, Dan
collection PubMed
description BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understanding the features of COVID-19-related ARDS (CARDS) and early management of this disease would improve the prognosis and reduce the mortality of severe COVID-19. With the development of recent studies which have focused on CARDS, whether CARDS is “typical” or “atypical” ARDS has become a hotly debated topic. METHODS: We searched for relevant literature from 1999 to 2021 published in PubMed by using the following keywords and their combinations: “COVID-19”, “CARDS”, “ARDS”, “pathophysiological mechanism”, “clinical manifestations”, “prognosis”, and “clinical trials”. Then, we analyzed, compared and highlighted the differences between classic ARDS and CARDS from all of the aspects above. KEY CONTENT AND FINDINGS: Classical ARDS commonly occurs within 1 week after a predisposing cause, yet the median time from symptoms onset to CARDS is longer than that of classical ARDS, manifesting within a period of 9.0–12.0 days. Although the lung mechanics exhibited in CARDS grossly match those of classical ARDS, there are some atypical manifestations of CARDS: the severity of hypoxemia seemed not to be proportional to injury of lung mechanics and an increase of thrombogenic processes. Meanwhile, some patients’ symptoms do not correspond with the extent of the organic injury: a chest computed tomography (CT) will reveal the severe and diffuse lung injuries, yet the clinical presentations of patients can be mild. CONCLUSIONS: Despite the differences between the CARDS and ARDS, in addition to the treatment of antivirals, clinicians should continue to follow the accepted evidence-based framework for managing all ARDS cases, including CARDS.
format Online
Article
Text
id pubmed-9469157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-94691572022-09-14 A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? Pu, Dan Zhai, Xiaoqian Zhou, Yuwen Xie, Yao Tang, Liansha Yin, Liyuan Liu, Hangtian Li, Lu Ann Transl Med Review Article BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understanding the features of COVID-19-related ARDS (CARDS) and early management of this disease would improve the prognosis and reduce the mortality of severe COVID-19. With the development of recent studies which have focused on CARDS, whether CARDS is “typical” or “atypical” ARDS has become a hotly debated topic. METHODS: We searched for relevant literature from 1999 to 2021 published in PubMed by using the following keywords and their combinations: “COVID-19”, “CARDS”, “ARDS”, “pathophysiological mechanism”, “clinical manifestations”, “prognosis”, and “clinical trials”. Then, we analyzed, compared and highlighted the differences between classic ARDS and CARDS from all of the aspects above. KEY CONTENT AND FINDINGS: Classical ARDS commonly occurs within 1 week after a predisposing cause, yet the median time from symptoms onset to CARDS is longer than that of classical ARDS, manifesting within a period of 9.0–12.0 days. Although the lung mechanics exhibited in CARDS grossly match those of classical ARDS, there are some atypical manifestations of CARDS: the severity of hypoxemia seemed not to be proportional to injury of lung mechanics and an increase of thrombogenic processes. Meanwhile, some patients’ symptoms do not correspond with the extent of the organic injury: a chest computed tomography (CT) will reveal the severe and diffuse lung injuries, yet the clinical presentations of patients can be mild. CONCLUSIONS: Despite the differences between the CARDS and ARDS, in addition to the treatment of antivirals, clinicians should continue to follow the accepted evidence-based framework for managing all ARDS cases, including CARDS. AME Publishing Company 2022-08 /pmc/articles/PMC9469157/ /pubmed/36111011 http://dx.doi.org/10.21037/atm-22-3717 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article
Pu, Dan
Zhai, Xiaoqian
Zhou, Yuwen
Xie, Yao
Tang, Liansha
Yin, Liyuan
Liu, Hangtian
Li, Lu
A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title_full A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title_fullStr A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title_full_unstemmed A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title_short A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
title_sort narrative review of covid-19-related acute respiratory distress syndrome (cards): “typical” or “atypical” ards?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469157/
https://www.ncbi.nlm.nih.gov/pubmed/36111011
http://dx.doi.org/10.21037/atm-22-3717
work_keys_str_mv AT pudan anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT zhaixiaoqian anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT zhouyuwen anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT xieyao anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT tangliansha anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT yinliyuan anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT liuhangtian anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT lilu anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT pudan narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT zhaixiaoqian narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT zhouyuwen narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT xieyao narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT tangliansha narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT yinliyuan narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT liuhangtian narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards
AT lilu narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards